Kewin Siah

🌏 Join us in Jakarta for ANMA 2025 🇮🇩 — the premier neurogastroenterology event in Asia!
📆 4–6 September 2025
🏨 Ritz Carlton Mega Kuningan Hotel
🤝 In conjunction with IDDW 2025
Let’s advance #DGBI care together!
🔗 [https://iddwanma2025.com/]
#ANMA2025 #IDDW2025 #Neurogastroenterology #GIcare #Jakarta

2025 Seoul Consensus on Clinical Practice Guidelines for Irritable Bowel Syndrome Yonghoon Choi, Young Hoon Youn, Seung Joo Kang, Jeong Eun Shin, Young Sin Cho, Yoon Suk Jung, Seung Yong Shin, Cheal Wung Huh, Yoo Jin Lee, Hoon Sup Koo, Kwangwoo Nam, Hong Sub Lee, Dong Hyun Kim, Ye ...

The Korean🇰🇷 #IBS consensus is comprehensive, pragmatic, and harmonizes Western evidence with regional practice constraints, drug availability, and increasing psychosocial attention.
www.jnmjournal.org/journal/view...
#GIsky #DGNIsky

We’ve put this sticker up in our hospital loo for #WorldIBSDay—proud to partner with NUHS+ to shine a light on IBS‑C.

👉 nuhsplus.edu.sg/article/back...

#GISky #DGBISky

🆕 2025 USMSTF Bowel Prep Recommendations:
✅ Split-dose still #1
✅ 2L preps now preferred 💧
✅ Same-day OK for PM scopes (not AM)
✅ Low-residue > clear liquid diet
❗ Aim for >90% adequate prep
🤔 Simethicone? Possibly helpful.

🔓 Full text: www.giejournal.org/article/S001...
#GIsky #MEdedsky

🧠💻 The AGA 2025 Guideline on CADe-assisted colonoscopy makes no recommendation—due to very low certainty in reducing #CRC incidence or mortality.
✅ ADR improve ⚠️ But more low-risk polyp detection → increased surveillance, cost & patient burden. #GiSky #GutSky
www.gastrojournal.org/article/S001...

The Vibrating Capsule: Safety and Tolerability in Patients With Chronic Idiopathic Constipation - PubMed The Vibrating Capsule, a first in class treatment for CIC was found to be safe and well tolerated by patients in clinical trials. No patient discontinued treatment due to adverse events.

Vibrating Capsule shows promise in treating Chronic Constipation! Low adverse events (2.9% bloating, 2.9% abdominal pain) and high patient satisfaction (83% convenient, 71% satisfied). Read more: (link unavailable) #GISky #MedSky #DGBI
👉https://pubmed.ncbi.nlm.nih.gov/40059867/

Efficacy of Linaclotide in Functional Dyspepsia and Constipation-Predominant Irritable Bowel Syndrome Overlap: A Randomized Trial - PubMed ClinicalTrials.gov: NCT05134584.

📚 New Research: Linaclotide outperforms Lactulose for treating Functional Dyspepsia + IBS-C overlap. 🌟
✅ 87.2% of patients on Linaclotide reported symptom relief vs just 54.2% on Lactulose
📈 Bloating, abdominal discomfort, stool frequency
🔬 pubmed.ncbi.nlm.nih.gov/40079184/
#GutSky #IBSSky #DGBI

"Constipation is a common GI symptom in pure autonomic failure, affecting nearly half of patients. It often shows up alongside other autonomic issues, highlighting the complexity of managing this condition. 🧠🚽 #NeurologySky #GutSky #ANSSky #https://pubmed.ncbi.nlm.nih.gov/40053259/

pmc.ncbi.nlm.nih.gov/articles/PMC...

🚨 What raises your risk of #IBS? A new umbrella review of 69 systematic reviews highlights key factors: female gender, anxiety, depression & gastroenteritis. How can we improve prevention? #GutHealth #DGBISky #GISky

🚀 A breakthrough in motility testing! The #AtmoCapsule emerges as a solid alternative to the discontinued #SmartPill, showing strong correlation for gastric emptying & colonic transit times. A new era for GI transit assessment? #DrGutBrainExplains #GISky #DGBISky
🔓 www.cghjournal.org/article/S154...

🔥New study: Psychological stress can break oral tolerance to food, triggering IgE-mediated mast cell activation & gut pain hypersensitivity—offering insights into stress-induced IBS. #GISky #GutSky #DGBI #MedSky
📃https://els-jbs-prod-cdn.jbs.elsevierhealth.com/article/S0016-5085(25)00371-3/fulltext

Kudos to @AndySamberg & @BowenYang for tackling anxiety & #IBS in their #SNL song! Using comedy to break down stigma & spark conversations. Authentic representation matters! #MentalHealthMatters #GutHealthMatters #GITwitter
👉https://youtu.be/k94SUJ8UMKk?si=1QZhXfJO-L5RgDy_

First meeting of the APAGE Emerging Leader Committee DGBI Special Interest Group! Discussing initiatives for 2025 and beyond. Stay tuned for updates! #GiSky #GutSky

Can't wait to reconnect with old friends at #DDW2025! 📷 So many events, so little time! See you all in 77 days and 4 hours! 📷📷 #BeGutsy #gicommunity #ddw2025 #DGBI #GISky #GutSky

New study shows an IgG-based elimination diet improved #IBS symptoms in 59.6% of patients vs 42.1% on a sham diet (n=223). Interesting, but subgroup analysis suggests it may work better for IBS-C and IBS-M than IBS-D. #GISky #GutSky #DGBI pubmed.ncbi.nlm.nih.gov/39894284/

Advanced #Parkinson’s led to severe colonic dysmotility, fecal impaction, & kidney issues in a 77-yr-old. Treated with rectal tube + meds, but no cure for alpha-synuclein damage. 🚨 Early recognition key! #stoolcankill 🧠💩 #GISky #GutSky #constipation #DGBI #FGID pubmed.ncbi.nlm.nih.gov/39917098/

Sky Follower Bridge Instantly find and follow the same users from your 𝕏 followers on Bluesky

Are you thinking of signing up for #BlueSky?

▶️Use Sky follower bridge extension to follow people on bluesky that you follow on twitter! I
www.sky-follower-bridge.dev/get-started....

▶️Follow me! @kewinsiah.bsky.social

Check out the #BlueSky's #DGBI Starter Pack also! 🌟➡️https://go.bsky.app/5PZzEvd

#Stoolcankill: Rare case of ileal fecaloma causing small bowel obstruction in a 60yo 🧓with chronic #constipation. Surgical intervention successfully resolved the obstruction. Highlights importance of considering fecaloma in SBO differentials. #GiSky #Gutsky #DGBI pubmed.ncbi.nlm.nih.gov/39905511/

Welcome to the #DGBI Starter Pack!

Action Intent Links | Bluesky Authors, websites, and apps can use action intent links to implement "Share on Bluesky" buttons, or similar in-app actions. Logged-in users will be directed to the corresponding action view in the Blu...

We strongly suggest that academic publishers and other platforms that host research rapidly implement a Share to Bluesky button for their articles. Here's how:

docs.bsky.app/docs/advance...

#AcademicSky #HigherEd #Altmetrics

Gastroparesis: the chronic feeling of bloating, nausea & upper GI discomfort. With #GLP1 helping to boost the prevalence to 1-2% of the population, is it finally getting the attention it deserves?

🧵⬇️

#gisky #gastrosky #gastroparesis #IBD

Digital eHealth vs onsite 2-day IBS education: Digital program significantly ⬇️ symptom severity in 41% of pts & improved QoL, anxiety, depression. Both interventions scored high on client satisfaction. eHealth is a viable, for IBS self-management. #GutSky #GISky humanfactors.jmir.org/2025/1/e43618

#Gastroparesis Dx requires Sx like nausea/vomiting; asymptomatic cases excluded. N&V are key; bloating, pain less linked to severity. Overlaps with #FDyspepsia, but distinct patterns. QoL, mental health impacted. Weight loss not always present. #GutSky #GISky www.thelancet.com/journals/lan...

🚨 New @AmerGastroAssn update! 🚨 Screening & surveillance are key for #gastric cancer prevention in high-risk U.S. groups. Endoscopy + H. pylori eradication = crucial steps. Personalized risk-based approach needed. 🔗 doi.org/10.1053/j.ga... #GISky #medsky #GutSky

Impact of comorbid constipation on the survival of patients with heart failure: a multicenter, prospective cohort study conducted in Japan - PubMed Constipation can negatively affect the survival of patients with heart failure. Although the causal link between constipation and decreased survival remains unclear, identifying comorbid constipation ...

A Japanese multicenter study found that comorbid #constipation was linked to a 90%⬆️mortality risk in #HeartFailure pts (P < 0.001) Among 715 patients, those with constipation had worse 2-year survival and higher cardiovascular mortality. #GISky #CardioSky #HeartSky
pubmed.ncbi.nlm.nih.gov/39877026/

Specialty laboratory testing for chronic abdominal pain in irritable bowel syndrome - PubMed The findings emphasize the effectiveness and importance of adhering to Rome IV criteria, as advanced testing often fails to improve diagnostic accuracy and increases unnecessary healthcare costs.

🔍 Overtesting in IBS? A study of 26,732 IBS patients found that 85.3% of advanced serologic tests were ordered by GIs, yet only 12.5% followed guidelines, with a mere 2.1% positive rate. 💰 $39K wasted on unnecessary tests. Stick to Rome IV criteria! #GISky #GutSky
pubmed.ncbi.nlm.nih.gov/39853154/

🌟 Recognizing #DGBI in patients with organic GI disease remission prevents overtreatment with risky drugs and ensures targeted care. Let’s focus on better outcomes! 👉 bit.ly/3Ee3iwv #GISky #MedSky #GutSky

New insights from the Rome Foundation Report:

DGBI overlaps across GI & non-GI regions suggest a spectrum of disorders.
Persistent symptoms in organic GI disease remission need careful diagnosis.
Multidisciplinary care + gut-brain axis therapies = the future. #GISky #GutSky #DGBI

Excited share that our @romefoundation.bsky.social Working Team's manuscript 📄 on Overlap in Disorders of Gut-Brain Interaction #DGBI is now published in @natrevgastrohep.bsky.social! Grateful for this amazing journey with global experts. Read here: nature.com/articles/s41...
#DGBI #GISky #GutSky